Surgery Partners, Inc. (SGRY) News
Track canonical SquawkNews coverage tagged to SGRY, Surgery Partners, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid Services moved to cancel Affordable Care Act coverage for roughl
REGULATION | Sep 23, 2026, 08:42 PM UTC
H
Surgery Partners Updates FY2026 Revenue Guidance To $3.08B-$3.18B, Adjusted EBITDA To At Least $489M Following Idaho Falls Sale
Surgery Partners Updates FY2026 Revenue Guidance To $3.08B-$3.18B, Adjusted EBITDA To At Least $489M Following Idaho Falls Sale
LIVE | Sep 17, 2026, 01:07 PM UTC
M
Surgery Partners closes Idaho Falls sale for $797M, updates 2026 guidance
Surgery Partners says it completed the sale of its Idaho Falls facilities to Intermountain Health, receiving $797M gross and $587M net proceeds (subject to adjustments), and updated full-year 2026 guidance to reflect the
MNA | Sep 17, 2026, 01:03 PM UTC
M
Surgery Partners adjusts FY revenue outlook to $3.08B-$3.18B
Surgery Partners (SGRY) adjusted its full-year revenue view to $3.08B-$3.18B.
EARNINGS | Sep 17, 2026, 01:02 PM UTC
L
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est
Surgery Partners (NASDAQ: SGRY ) affirms FY2026 sales outlook from $3.350 billion-$3.450 billion to $3.350 billion-$3.450 billion vs $3.408 billion estimate.
EARNINGS | Aug 10, 2026, 11:30 AM UTC
H
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est
Surgery Partners (NASDAQ: SGRY ) affirms FY2026 sales outlook from $3.350 billion-$3.450 billion to $3.350 billion-$3.450 billion vs $3.408 billion estimate.
EARNINGS | Jul 24, 2026, 01:04 PM UTC
L
SGRY Surgery Partners - reaffirms 2026 revenue outlook of $3.35B-$3.45B and adj EBITDA of at least $530M
SGRY Surgery Partners - reaffirms 2026 revenue outlook of $3.35B-$3.45B and adj EBITDA of at least $530M
EARNINGS | Jul 24, 2026, 01:00 PM UTC